ASCO 2019
AbbVie’s Venclyxto combo outclasses chemo in treatment-naive chronic lymphocytic leukaemia
June 5, 2019Research and Development ASCO 2019, AbbVie, Venclyxto, pharma
AbbVie was one of many companies to present new data at this year’s American Society of Clinical Oncology (ASCO) Annual …
Darzalex combo makes strong Phase 3 showing in multiple myeloma
June 4, 2019Manufacturing and Production, Research and Development ASCO 2019, Cancer, Janssen, darzalex, multiple myeloma, pharma
Janssen joined its contemporaries at the 55th American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago in the release …
Janssen’s Erleada combo smashes endpoints in advanced hormone-sensitive prostate cancer
June 3, 2019Research and Development, Sales and Marketing ASCO 2019, Cancer, Erleada, Janssen, prostate cancer
Janssen joined the showing at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago to present new …
